logo
Reader Letter for Diversity, Equity, Inclusion and Accessibility Magazine 2023

Reader Letter for Diversity, Equity, Inclusion and Accessibility Magazine 2023

As 2023 draws to a close, Diversity, Equity, Inclusion and Accessibility (DEIA) remains a perennial hot-button topic that companies, no matter what business they're in, must contend with not only to function on a day-to-day basis but to sustain future growth.
It is clear that implementing DEIA initiatives is vital for recruiting and retaining talent as well as attracting investors, but many businesses are slow to adopt clear objectives and actionable strategies. More awareness, transparency and effort are needed to drive change and instill a sense of acceptance among the workforce across America.
On October 19, L.A. Times B2B Publishing hosted the 2023 DEIA Forum at the SLS Hotel in Beverly Hills. A number of informative panel discussions, featuring diversity leaders from a variety of industries, enlightened attendees with firsthand advice and insights on several relevant topics, including the urgent need for increased accessibility, how DEIA proponents are breaking barriers and belonging in a remote workspace culture. We summarize each panel here in the pages of this magazine.
I would like to thank each of the sponsors who helped make the event possible. We greatly appreciate the support of Diamond Sponsor The Change Company and Platinum Sponsors CommonSpirit Health, Easterseals Southern California, Phaidon International and University of West Los Angeles.
New this year is the Top Rated Workplaces in Southern California Survey where we rank small and midsize-large companies based on employees' anonymous replies to a questionnaire sent out by our partner DataJoe. The results follow several informative articles on trending DEIA news.
In the remaining pages, we're proud to recognize individuals at numerous Southern California companies who are spearheading change and leading the way to creating more inclusive workplaces.
We hope you are inspired by their achievements in this realm.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TransMedics Group, Inc. (TMDX): A Bull Case Theory
TransMedics Group, Inc. (TMDX): A Bull Case Theory

Yahoo

timean hour ago

  • Yahoo

TransMedics Group, Inc. (TMDX): A Bull Case Theory

We came across a bullish thesis on TransMedics Group, Inc. on Global Equity Briefing's Substack by Ray Myers. In this article, we will summarize the bulls' thesis on TMDX. TransMedics Group, Inc.'s share was trading at $118.97 as of July 31st. TMDX's trailing and forward P/E were 59.75 and 62.11 respectively according to Yahoo Finance. A surgeon in a modern operating theatre performing a transplant surgery with medical technology. TransMedics is revolutionizing the organ transplant ecosystem through its Organ Care System, a technology designed to keep organs warm, oxygenated, and viable far longer than traditional cold storage. By tackling key bottlenecks—organ degradation, low utilization rates, and logistical constraints—Organ Care System significantly extends transplant windows and boosts usage rates. Clinical trial data highlights its transformative potential: expanded criteria lungs and hearts saw utilization jump to 87% and 81%, respectively, while DCD heart use rose from 0% to 89%. TMDX monetizes this impact through a razor-and-blade model—selling Organ Care System consoles and high-margin, single-use consumables—while providing end-to-end services through its National Organ Care System Program, a SaaS-like Organs as a Service platform. With 21 private jets, 17 procurement hubs, and trained staff, TMDX handles organ retrieval, transport, and maintenance, positioning itself as a logistics powerhouse in the transplant chain. The opportunity is vast: U.S. underutilization alone represents a $400M+ annual consumables revenue potential, and TMDX currently serves just 3% of the $39B global market expected by 2034. Future growth catalysts include a kidney Organ Care System by 2029, entry into international markets via a $200M facility in Italy, and scaling the National Organ Care System Program globally. Financially, the company achieved profitability in 2024, posting $441M in revenue and positive operating cash flow, though free cash flow remains negative due to capex-heavy expansion. Trading at a P/E of 91, investor returns hinge on continued execution, EU rollout, and successful kidney platform launch. If goals are met, the stock could double by 2030, but slower expansion or margin compression may limit upside. Previously, we covered a on TransMedics Group, Inc. by Oliver | MMMT Wealth in May 2025, which highlighted warm perfusion technology, strong execution, and real-time flight data as revenue indicators. The company's stock appreciated ~24% since Q1 outperformance played out. Ray Myers shares a similar view but emphasizes the SaaS-like NOP model and global expansion potential. TransMedics Group, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 23 hedge fund portfolios held TMDX at the end of the first quarter which was 29 in the previous quarter. While we acknowledge the potential of TMDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None.

Wells Fargo gives CEO Scharf a $30M award, names him chair
Wells Fargo gives CEO Scharf a $30M award, names him chair

Yahoo

time10 hours ago

  • Yahoo

Wells Fargo gives CEO Scharf a $30M award, names him chair

This story was originally published on Banking Dive. To receive daily news and insights, subscribe to our free daily Banking Dive newsletter. Wells Fargo intends to give CEO Charlie Scharf a $30 million one-time equity award and install him as chair of its board, in addition to serving as chief executive, the bank announced Thursday. The move is meant to lock Scharf into leading Wells for the next six years and recognize his role in restoring the bank's reputation, boosting its risk and control infrastructure, and identifying and investing in 'core' business areas. Regulators have terminated 13 consent orders against Wells since Scharf became CEO in 2019, including a $1.95 trillion asset cap the Federal Reserve lifted in June – a remnant of the bank's 2016 fake-accounts scandal. Wells did not give a timeline for handing the chair role to Scharf – nor did it detail a future role for the bank's current chair, Steven Black. The bank did, however, note that it intends to appoint a lead independent director. Scharf and Black have served together before; Black was a director on BNY's board when Scharf served as chair and CEO of the bank in 2018 and 2019. 'We are thrilled to recognize Charlie's significant contributions to Wells Fargo,' Black said in a statement. 'We look forward to Charlie's continued guidance and strategic direction as we navigate the future." Depending on the timing, Wells could become the third U.S.-based systemically important financial institution to combine its chair and CEO roles this year. BNY in June named CEO Robin Vince to concurrently serve as its chair, starting Sept. 1. Morgan Stanley CEO Ted Pick assumed chair responsibilities Jan. 1. That leaves Citi as the only U.S. SIFI (there are eight) to maintain separate chair and CEO roles. Scharf would also become at least the third CEO of a top-10 U.S. bank this year to receive an eight-figure equity award. Goldman Sachs disclosed in January that it would give CEO David Solomon an $80 million retention bonus. The bank gave the same deal to President John Waldron, drawing criticism from proxy advisers this spring. Capital One, meanwhile, granted CEO Richard Fairbank a $30 million one-time award in June after the bank closed its long-running acquisition of Discover. Scharf's award is not limited to $30 million in restricted share rights. He also is set to receive 1,046,000 stock options. The award will vest on a pro rata basis following the fourth, fifth and sixth anniversaries of the grant date. Unvested portions of the award will be forfeited if Scharf resigns or retires earlier, the bank said. Also, Scharf must keep at least 50% of the vested shares throughout his time at Wells and a year after he leaves, according to the bank. Scharf, in a statement Thursday, largely deferred to his team. 'Over the last several years, our Operating Committee and our 213,000 employees have executed a multi-faceted transformation under extremely difficult circumstances,' he said. 'It is a privilege to lead Wells Fargo and our talented and dedicated team, and I look forward to building on our significant momentum to continue improving our performance and market position in everything we do.' The award further stabilizes leadership at Wells and removes any incentive Scharf might have to explore options outside of the bank. Observers have casually speculated that Scharf could have been a dark-horse candidate to succeed mentor Jamie Dimon as CEO of JPMorgan Chase. Dimon has hinted that the clock is ticking on his tenure atop the bank, and a series of personnel moves – first in 2021, then last year and again this year (twice) – has alternately raised the profiles of various potential internal successors. The value of Scharf's award will fluctuate along with Wells' stock price, the bank said. The options, for their part, will only have value insofar as the bank's stock price appreciates throughout the vesting period. Scharf wasn't the only Wells executive whose compensation came under the microscope. Wells' human resources committee decided not to keep a target total compensation structure for its named executive officers, the bank said Thursday in a filing with the Securities and Exchange Commission. The panel, rather, will 'determine incentive compensation for each NEO, including the CEO, using a holistic performance assessment that evaluates NEO performance based on individual and Company performance, as well as line of business performance, where applicable, relative to established financial and non-financial performance criteria,' the bank said. Scharf will be Wells' first CEO-chair hybrid in nearly a decade. The bank changed its bylaws after former Chair and CEO John Stumpf resigned in October 2016, to require an independent chair. Wells amended those bylaws this week to allow Scharf to serve in a dual capacity. Another new amendment requires the bank to maintain an independent lead director. Recommended Reading BNY names CEO Robin Vince as its next chair

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store